Page last updated: 2024-08-23

4-methoxyamphetamine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

4-methoxyamphetamine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambühl, P; Cole, E; Fauchald, P; Fellström, B; Gimpelwicz, C; Grönhagen-Riska, C; Holdaas, H; Holme, I; Jardine, AG; Madsen, S; Maes, B; Neumayer, HH; Nyberg, G; Olsson, AG; Pedersen, TR	1
Ambühl, P; Cole, E; Fellström, B; Gimpelewicz, C; Grönhagen-Riska, C; Holdaas, H; Jardine, AG; Logan, JO; Madsen, S; Maes, B; Neumayer, HH; Nyberg, G; Staffler, B	1
Sedgwick, P	1

Trials

2 trial(s) available for 4-methoxyamphetamine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:6 Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol, LDL; Death; Double-Blind Method; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Humans; Indoles; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Placebos; Risk Factors; Treatment Outcome	2004
Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:5 Topics: Adult; Cholesterol, LDL; Death; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Risk Reduction Behavior	2005

Article

Year

fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:6

Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol, LDL; Death; Double-Blind Method; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Humans; Indoles; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Placebos; Risk Factors; Treatment Outcome

2004

Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:5

Topics: Adult; Cholesterol, LDL; Death; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Risk Reduction Behavior

2005

Other Studies

1 other study(ies) available for 4-methoxyamphetamine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Sample size calculations I. BMJ (Clinical research ed.), 2010, Jun-16, Volume: 340 Topics: Anticholesteremic Agents; Death; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Myocardial Infarction; Sample Size	2010